Viall Co., Ltd. (CEO Lee Sang-jin) announced that it will participate in the 3th International Medical Equipment & Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26 (Thu) to 38 (Sun).
Viol is a specialized company that researches and produces medical devices that combine biotechnology and electronic technology. Bio-electro technology is still an unfamiliar field, but the company explains that it is constantly researching and continuously expanding investment in facilities to become a global leader in bio-electro that will open a new era.
In this exhibition, ‘SYLFIRM X’ will be exhibited. Silfirm X, a dual-wave high-frequency microneedling system, uses pulsed wave (PW) suitable for pigment and vascular lesions such as melasma and redness, and continuous wave (CW) suitable for skin regeneration, lifting & tightening, and scar treatment. are available and feature a depth of 300 μm. Silferm X, which has 8 PW/CW modes, has proven its effectiveness and safety through FDA approval and more than 25 clinical studies and experiments.
Silfirm X’s needle depth adjustment range is 0.3 to 4.0 mm, and it is possible to target the papillary dermis layer located at a depth of 300 μm in the skin. The advantage was that the pain was minimal and the patient could quickly return to daily life.
An official from Viol said, “The 300㎛ target treatment improves the factors that cause pigment and vascular lesions, relieves symptoms more quickly, strengthens the basement membrane, improves skin texture and elasticity, and makes the skin healthy with the effect of increasing TYPE 3 collagen, which is most important for maintenance. give,” he explained.
In addition, ‘SCARLET S’, which will be introduced together, is also FDA-approved technology and safety-guaranteed equipment. Needles that can be precisely adjusted in depth from 0.5 to 3.5 mm deliver precise heat energy to the epidermis and dermis. It also provides efficient and stable RF energy.
An official said, “The RF energy of SCARLET S is continuously irradiated to the tissue for a set conduction time. It applies heat of 55 to 60 degrees by accurately delivering stable RF energy to a wider area at once. This temperature induces tissue protein denaturation or collagen coagulation, which stimulates the wound healing process and dermal remodeling.”
“The core source technology of Viol, ‘Na Effect’, was discovered in a study that observed the skin reaction of bipolar RF using non-insulated microneedles. In the ‘Na Effect’, tissue coagulation begins at the tip of the microneedle electrode, and as the conduction time increases, a droplet-shaped thermal coagulation point is formed, which transmits energy widely and causes less thermal damage to the epidermis.”
The product development background was also revealed. An official said, “A medical device with high-frequency microneedling technology was developed based on the experience of Dr. Ra Jong-joo, who is currently an advisory member of Viol and a former doctor. Dr. Ra Jong-joo has secured a patented technology for high-frequency medical devices through an R&D process to overcome the limitations of using existing skin treatments. After securing high-frequency patent technology, continuous high-frequency-based SCATLET was released in 2010 and pulse-type high-frequency medical device SYLFIRM in 2016, one after another.”
In 2020, SYLFIRM X, which combines the strengths of Scarlett and Silfirm, was launched, and after approval by the US FDA, it is exported to North America, Central and South America, Europe, Asia, and the Middle East, expanding its presence in the global market. Viall announced that, as a result of aggregating performance in the third quarter of 2022, sales increased by 3% and operating profit by 65% from the same period last year, and the operating margin reached 131%. Cumulative sales increased by 50% from the same period last year, exceeding 75 billion won last year, recording the highest performance ever.
In addition to participating in exhibitions in each country, strengthening marketing activities such as hosting domestic and international academic events such as the Silfirm X Global Symposium, Indonesia training seminar, and domestic user meeting, which invited prominent overseas doctors, and active overseas exports, 2018 million dollars in 500, 2020 million dollars in 700, It won the 2022 million dollar export tower in 1, and continues to show steady performance.
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
KIMES 2023 will feature new technologies and new products suitable for the era of convergence, such as smart healthcare in the era of the 4th Industrial Revolution, robotic medicine and eco-friendly medical waste facilities, cutting-edge hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation. presents. In addition, it provides a variety of information, including seminars on medical technology, new technology, and overseas marketing, as well as domestic medical industry policy seminars that will show the latest information and direction of the medical industry.